Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 195 results found. Search for [ drug patents ]

Results 1 to 21 of 195
PTI
May 5, 2021
If the US gives up intellectual property rights, it will harm innovation and production, and result in fewer people getting vaccinated, the 12 influential Congressmen said in a letter to US Trade Representative Katherine Tai


PB Jayakumar
May 3, 2021
Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing


BusinessToday.In
March 25, 2021
Shares of Craftsman Automation, Anupam Rasayan, Laxmi Organic Industries, Adani Green, Cadila, TVS Motors, Bank of India, Jubilant FoodWorks will be in focus in Thursday's trading session


BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery


PTI
March 6, 2021
This liquidation was a part of internal reorganisation and it will not affect performance or revenue of the company, says Cipla


PB Jayakumar
February 26, 2021
SS Innovations is planning to make 100 units this year of the multi arm novel 'Mantra' Surgical Robotic System indigenously developed over the last three years. Plans are to make and sell over 1,000 units within the next five years


BusinessToday.In
January 5, 2021
Without naming Serum Institute CEO Adar Poonawalla, who had termed vaccines other than that of Pfizer, Moderna and Oxford-AstraZeneca as 'just like water', Krishna Ella said, 'We do 200 per cent honest clinical trials and yet we receive backlash'


PB Jayakumar
December 10, 2020
Though Pfizer India says it remains committed to advance dialogue with Indian government to make the vaccine available for use, experts believe it will be difficult for its parent to supply adequate quantities of the vaccine


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


BusinessToday.In
November 17, 2020
Pfizer filed a possible patent infringement petition against both companies in the United States District Court for the District of Delaware and two counts last week


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


Joe C Mathew
October 13, 2020
In most cases, AstraZeneca gathered information about marketing approvals from the state departments by using the RTI (Right to Information Act) route


Joe C Mathew
October 7, 2020
Parallel to the WTO proposal, SJM wants India to initiate measures under Section 66 of the Patents Act for the cancelation of the patent on Remdesivir


BusinessToday.In
September 17, 2020
As part of the settlement, Celgene has agreed to provide Dr Reddy's with a licence to sell volume-limited amounts of generic lenalidomide capsules in the US after March 2022 subject to regulatory approval


BusinessToday.In
September 12, 2020
Bharat Biotech says its vaccine candidate was found to generate \"robust immune responses\", thus preventing infection and disease in primates upon high amounts of exposure to live SARS-CoV-2 virus


BusinessToday.In
August 19, 2020
Jairam Ramesh says India depends on China for most of its active pharmaceutical ingredients, and during coronavirus-induced lockdown in May and June, API prices shot up steeply, exposing India's vulnerabilities


Prasanna Mohanty
July 27, 2020
Profit-driven enterprises are ill-suited to protect the health and life of a vast majority of people, as the US and Indian governments experience, but do precious little, thereby failing in their primary duty


Reuters
July 27, 2020
In April, Moderna had received $483 million from the U.S. federal agency that funds disease-fighting technology, when the experimental vaccine was in an early-stage trial conducted by the U.S. National Institutes of Health


E Kumar Sharma
July 1, 2020
Avigan, an antiviral drug to fight influenza, is believed to be effective in treatment of COVID-19 patients


PTI
July 1, 2020
Fujifilm is conducting a clinical study on Avigan to treat COVID-19 patients in Japan and the United States and has been seeking to increase the drug's production by partnering with domestic and overseas companies


PAGES 1 OF 10  12345